AMRYT PHARMA
Amryt Pharma is a specialty pharmaceutical company focused on the developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt’s lead product, Episalvan, received marketing approval for the treatment of partial-thickness wounds from the European Commission in January 2016. Amryt intends to further develop Episalvan as a new treatment for a hereditary skin disorder called Epidermolysis Bullosa in both Europe and the U.S. Amryt’s earlier stage products are focussed on developing novel, next generation somatostatin analogue (“SSA”) peptide medicines for patients with rare neuroendocrine diseases, where there is high unmet medical needs. These include acromegaly and Cushing's disease.
AMRYT PHARMA
Industry:
Medical Pharmaceutical
Founded:
2012-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.amrytpharma.com
Total Employee:
51+
Status:
Active
Contact:
41 79 818 31 28
Email Addresses:
[email protected]
Total Funding:
146.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-05 | Chiasma | Chiasma acquired by Amryt Pharma | N/A |
| 2019-03-20 | Aegerion Pharmaceuticals | Aegerion Pharmaceuticals acquired by Amryt Pharma | N/A |
| 2016-05-13 | Sompharmaceuticals | Sompharmaceuticals acquired by Amryt Pharma | N/A |
Investors List
Ares Management
Ares Management investment in Post-IPO Debt - Amryt Pharma
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Amryt Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-27 | Amryt Announces Appointment of Dr Tracy Cunningham as Chief Medical Officer |
Official Site Inspections
http://www.amrytpharma.com Semrush global rank: 6.73 M Semrush visits lastest month: 840
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
